Skip to main content

MoneyWorks4Me

Divis Laboratories informs about quarterly statement on investor complaints

12 Jul 2016 Evaluate

Divis Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1747.95
Dr. Reddys Labs. 1355.70
Cipla 1378.60
Lupin 2008.45
Zydus Lifesciences 1238.00
View more..